drugset / Trial / NCT05682807
Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is to evaluate the effectiveness of caffeine versus probiotics supplementation as adjuvant therapy for preterm neonates with Bronchopulmonary dysplasia (BPD).
Timeline
- Start
- 2022-06-30
- Primary completion
- 2024-06
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Caffeine | Small molecule | 5 mg/kg | Intravenous |
| Comparator | Caffeine | Small molecule | 10 mg/kg | Intravenous |
| Comparator | Probio Tec BB12-Blend 30- IF | Other / unclassified | 100 mg | Oral |